209 related articles for article (PubMed ID: 33704048)
1. The efficacy of add-on ramelteon and subsequent dose reduction in benzodiazepine derivatives/Z-drugs for the treatment of sleep-related eating disorder and night eating syndrome: a retrospective analysis of consecutive patients.
Matsui K; Kuriyama K; Kobayashi M; Inada K; Nishimura K; Inoue Y
J Clin Sleep Med; 2021 Jul; 17(7):1475-1483. PubMed ID: 33704048
[TBL] [Abstract][Full Text] [Related]
2. Prompt improvement of difficulty with sleep initiation and waking up in the morning and daytime somnolence by combination therapy of suvorexant and ramelteon in delayed sleep-wake phase disorder: a case series of three patients.
Izuhara M; Kawano K; Otsuki K; Hashioka S; Inagaki M
Sleep Med; 2021 Apr; 80():100-104. PubMed ID: 33588260
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
[TBL] [Abstract][Full Text] [Related]
4. Ultra-low-dose early night ramelteon administration for the treatment of delayed sleep-wake phase disorder: case reports with a pharmacological review.
Shimura A; Kanno T; Inoue T
J Clin Sleep Med; 2022 Dec; 18(12):2861-2865. PubMed ID: 35929592
[TBL] [Abstract][Full Text] [Related]
5. A survey of the effects of ramelteon on benzodiazepine-dependence: Comparison between a ramelteon add-on group and a continuous benzodiazepine administration group.
Naono-Nagatomo K; Abe H; Araki R; Funahashi H; Takeda R; Taniguchi H; Ishida Y
Asian J Psychiatr; 2018 Aug; 36():20-24. PubMed ID: 29886401
[TBL] [Abstract][Full Text] [Related]
6. Ramelteon for the treatment of insomnia.
Borja NL; Daniel KL
Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapies for sleep disturbances in dementia.
McCleery J; Sharpley AL
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009178. PubMed ID: 33189083
[TBL] [Abstract][Full Text] [Related]
8. Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect.
Mini L; Wang-Weigand S; Zhang J
Clin Ther; 2008 Jul; 30(7):1316-23. PubMed ID: 18691991
[TBL] [Abstract][Full Text] [Related]
9. Ramelteon.
McGechan A; Wellington K
CNS Drugs; 2005; 19(12):1057-65; discussion 1066-7. PubMed ID: 16332146
[TBL] [Abstract][Full Text] [Related]
10. A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.
Roth T; Seiden D; Wang-Weigand S; Zhang J
Curr Med Res Opin; 2007 May; 23(5):1005-14. PubMed ID: 17519067
[TBL] [Abstract][Full Text] [Related]
11. A Cross-Sectional Study of Evening Hyperphagia and Nocturnal Ingestion: Core Constituents of Night Eating Syndrome with Different Background Factors.
Matsui K; Komada Y; Okajima I; Takaesu Y; Kuriyama K; Inoue Y
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836434
[TBL] [Abstract][Full Text] [Related]
12. The effects of ramelteon in a first-night model of transient insomnia.
Zammit G; Schwartz H; Roth T; Wang-Weigand S; Sainati S; Zhang J
Sleep Med; 2009 Jan; 10(1):55-9. PubMed ID: 18691937
[TBL] [Abstract][Full Text] [Related]
13. Melatonergic drugs in clinical practice.
Hardeland R; Poeggeler B; Srinivasan V; Trakht I; Pandi-Perumal SR; Cardinali DP
Arzneimittelforschung; 2008; 58(1):1-10. PubMed ID: 18368944
[TBL] [Abstract][Full Text] [Related]
14. Ramelteon: new drug. Insomnia: no role for risky placebos.
Prescrire Int; 2008 Oct; 17(97):183-6. PubMed ID: 19534018
[TBL] [Abstract][Full Text] [Related]
15. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
[TBL] [Abstract][Full Text] [Related]
16. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
Srinivasan V; Pandi-Perumal SR; Trahkt I; Spence DW; Poeggeler B; Hardeland R; Cardinali DP
Int J Neurosci; 2009; 119(6):821-46. PubMed ID: 19326288
[TBL] [Abstract][Full Text] [Related]
17. Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis.
Wang-Weigand S; McCue M; Ogrinc F; Mini L
Curr Med Res Opin; 2009 May; 25(5):1209-13. PubMed ID: 19327100
[TBL] [Abstract][Full Text] [Related]
18. Effects of Ramelteon and Other Sleep-Promoting Drugs on Serum Low-Density Lipoprotein and Non-high-density Lipoprotein Cholesterol: A Retrospective Comparative Pilot Study.
Torii H; Shimizu R; Tanizaki Y; Omiya Y; Yamamoto M; Kamiike S; Yasuda D; Hiraoka Y; Hashida T; Kume N
Biol Pharm Bull; 2018; 41(12):1778-1790. PubMed ID: 30504680
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Ramelteon on Heartburn Symptoms of Patients With Gastroesophageal Reflux Disease and Chronic Insomnia: A Pilot Study.
Jha LK; Fass R; Gadam R; Maradey-Romero C; Nasrollah L; Hershcovici T; Quan SF; Dickman R
J Clin Gastroenterol; 2016 Feb; 50(2):e19-24. PubMed ID: 25887111
[TBL] [Abstract][Full Text] [Related]
20. Correlation among clock gene expression rhythms, sleep quality, and meal conditions in delayed sleep-wake phase disorder and night eating syndrome.
Haraguchi A; Komada Y; Inoue Y; Shibata S
Chronobiol Int; 2019 Jun; 36(6):770-783. PubMed ID: 30917702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]